Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Investigators aim to compare the effects of early and late time-restricted feeding on overweight adults with metabolic syndrome
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Early time-restricted eating (eTRE) | Experimental | The eTRE group is instructed to consume all calories from 7 AM to 3 PM each day and fast from 3 PM to 7 AM |
|
| Late time-restricted eating (lTRE) | Experimental | The lTRE group is instructed toconsume all calories from 11 AM to 7 PM each day and fast from 7 PM to 11 PM |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Early time-restricted eating (eTRE) | Behavioral | The eTRE group is instructed to consume all calories in early 8h eating window, |
|
| Measure | Description | Time Frame |
|---|---|---|
| Changes in body weight | Body weight is assessed at the research center with the participants without shoes and in light clothing using a digital scale (OMRON MEDICAL Beijing Co., Ltd. HNH-318) to the nearest 0.1 kg. | 0-week; 6-week and 12-week |
| Changes in abdominal fat area | Abdominal fat area is measured using bioelectrical impedance analysis (OMRON MEDICAL Beijing Co., Ltd. DUALSCAN, HDS-2000) to the nearest 1 cm2. | 0-week; 6-week and 12-week |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in body composition ( body fat mass) | Body composition (body fat mass ) is measured using the dual-energy X-ray absorptiometry (DXA, Hologic Serie horzion-wi QDR., Bedford, MA, USA) | 0-week and 12-week |
| Changes in body composition (body muscle mass) |
Not provided
Inclusion Criteria:
Age from 18 to 65 years
Body mass index (BMI): 24.0-40.0 kg/m2
Diagnosed with metabolic syndrome (i.e., more than 3 abnormal findings out of 5):
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bingyin Shi | First Affiliated Hospital Xi'an Jiaotong University | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| First Affiliated Hospital of Xi 'an Jiaotong University | Xi'an | Shaanxi | 710061 | China |
There is no plan to make individual participant data (IPD) available to other researchers.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Late time-restricted eating (lTRE) | Behavioral | The lTRE group is instructed to consume all calories in late 8h eating window. |
|
Body composition ( body muscle mass) is measured using the dual-energy X-ray absorptiometry (DXA, Hologic Serie horzion-wi QDR., Bedford, MA, USA) |
| 0-week and 12-week |
| Changes in glycemic control | Plasma glucose is measured on an automatic biochemistry analyzer (HITACHI, Inc.; LAbOSPECT, 008AS) using standard reagents to the nearest 0.01 mmol/L; Serum insulin is measured by a magnetic particle chemiluminescence immunoassay (Kaeser 6600, Guangzhou Kangrun Co., Ltd., China) to the nearest 0.01 μIU/mL; | 0-week; 6-week and 12-week (glucose and insulin)0-week and 12-week (HbA1c) |
| Changes in hemoglobin A1c (HbA1c) | HbA1c is measured on an automatic HbA1c analyzer (TOSOH BIOSCIENCE, Inc.; HLC-723G8) to the nearest 0.1%. | 0-week; 6-week and 12-week (glucose and insulin)0-week and 12-week (HbA1c) |
| Changes in total cholesterol, triglyceride (TG), high-density lipoprotein cholesterol (HDL-c), and low-density lipoprotein cholesterol (LDL-c) | Plasma lipids of total cholesterol, TG, HDL-c, and LDL-c are measured on an automatic biochemistry analyzer (HITACHI, Inc.; LAbOSPECT, 008AS) using standard reagents to the nearest 0.01 mmol/L. | 0-week; 6-week and 12-week |
| Changes in uric acid (UA) | UA is measured on an automatic biochemistry analyzer (HITACHI, Inc.; LAbOSPECT, 008AS) using standard reagents to the nearest 1 µmol/L. | 0-week; 6-week and 12-week |
| Changes in blood pressure. | Blood pressure is measured in triplicate using a digital automatic blood pressure (Omron HBP-9020, Kyoto, Japan) to the nearest 1 mmHg. | 0-week; 6-week and 12-week |
| ID | Term |
|---|---|
| D024821 | Metabolic Syndrome |
| D050177 | Overweight |
| D009765 | Obesity |
| D000093763 | Intermittent Fasting |
| ID | Term |
|---|---|
| D007333 | Insulin Resistance |
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D005215 | Fasting |
| D005247 | Feeding Behavior |
| D001519 | Behavior |
Not provided
Not provided